Medical and Productivity Costs of Rheumatoid Arthritis in The Czech Republic: Cost-of-Illness Study Based on Disease Severity

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11130%2F14%3A10281743" target="_blank" >RIV/00216208:11130/14:10281743 - isvavai.cz</a>
Alternative codes found
RIV/00023728:_____/14:#0004049
Result on the web
<a href="http://www.sciencedirect.com/science/article/pii/S2212109914000582" target="_blank" >http://www.sciencedirect.com/science/article/pii/S2212109914000582</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.vhri.2014.07.004" target="_blank" >10.1016/j.vhri.2014.07.004</a>

Result language
angličtina
Original language name
Medical and Productivity Costs of Rheumatoid Arthritis in The Czech Republic: Cost-of-Illness Study Based on Disease Severity
Original language description
This was a retrospective cross-sectional study. We included 261 patients with RA, aged 18 to 84 years. We applied a bottom-up method by retrospectively reviewing individual patient medical records. Patients' demographic characteristics, patient-reportedoutcome, and clinical parameters were gathered at the time of data collection. For the calculation of productivity costs, we used the friction cost approach, based on patient absenteeism with a friction period of 130 workdays, with average monthly incomeused as the denominator. Costs were expressed as a mean value per patient with RA in each HAQ group.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FR - Pharmacology and apothecary chemistry
OECD FORD branch
—

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2014
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)